Atp7b-/- mice as a model for studies of Wilson's disease

Research output: Contribution to journalArticle

Abstract

Wilson's disease is a severe human disorder of copper homoeostasis. The disease is associated with various mutations in the ATP7B gene that encodes a copper-transporting ATPase, and a massive accumulation of copper in the liver and several other tissues. The most frequent disease manifestations include a wide spectrum of liver pathologies as well as neurological and psychiatric abnormalities. A combination of copper chelators and zinc therapy has been used to prevent disease progression; however, accurate and timely diagnosis of the disease remains challenging. Similarly, side effects of treatments are common. To understand better the biochemical and cellular basis of Wilson's disease, several animal models have been developed. This review focuses on genetically engineered Atp7b-/- mice and describes the properties of these knockout animals, insights into the disease progression generated using Atp7b-/- mice, as well as advantages and limitations of Atp7b-/- mice as an experimental model for Wilson's disease.

Original languageEnglish (US)
Pages (from-to)1233-1238
Number of pages6
JournalBiochemical Society Transactions
Volume36
Issue number6
DOIs
StatePublished - 2008
Externally publishedYes

Fingerprint

Hepatolenticular Degeneration
Copper
Disease Progression
Liver
Chelating Agents
Psychiatry
Zinc
Homeostasis
Theoretical Models
Animal Models
Pathology
Mutation
Animals
Genes
Therapeutics
Tissue

Keywords

  • ATP7A
  • ATP7B
  • Copper
  • Liver
  • Mouse model
  • Wilson's disease

ASJC Scopus subject areas

  • Biochemistry

Cite this

Atp7b-/- mice as a model for studies of Wilson's disease. / Lutsenko, Svetlana.

In: Biochemical Society Transactions, Vol. 36, No. 6, 2008, p. 1233-1238.

Research output: Contribution to journalArticle

@article{6b977d39b24345bb872d33c5f8f04289,
title = "Atp7b-/- mice as a model for studies of Wilson's disease",
abstract = "Wilson's disease is a severe human disorder of copper homoeostasis. The disease is associated with various mutations in the ATP7B gene that encodes a copper-transporting ATPase, and a massive accumulation of copper in the liver and several other tissues. The most frequent disease manifestations include a wide spectrum of liver pathologies as well as neurological and psychiatric abnormalities. A combination of copper chelators and zinc therapy has been used to prevent disease progression; however, accurate and timely diagnosis of the disease remains challenging. Similarly, side effects of treatments are common. To understand better the biochemical and cellular basis of Wilson's disease, several animal models have been developed. This review focuses on genetically engineered Atp7b-/- mice and describes the properties of these knockout animals, insights into the disease progression generated using Atp7b-/- mice, as well as advantages and limitations of Atp7b-/- mice as an experimental model for Wilson's disease.",
keywords = "ATP7A, ATP7B, Copper, Liver, Mouse model, Wilson's disease",
author = "Svetlana Lutsenko",
year = "2008",
doi = "10.1042/BST0361233",
language = "English (US)",
volume = "36",
pages = "1233--1238",
journal = "Biochemical Society Transactions",
issn = "0300-5127",
publisher = "Portland Press Ltd.",
number = "6",

}

TY - JOUR

T1 - Atp7b-/- mice as a model for studies of Wilson's disease

AU - Lutsenko, Svetlana

PY - 2008

Y1 - 2008

N2 - Wilson's disease is a severe human disorder of copper homoeostasis. The disease is associated with various mutations in the ATP7B gene that encodes a copper-transporting ATPase, and a massive accumulation of copper in the liver and several other tissues. The most frequent disease manifestations include a wide spectrum of liver pathologies as well as neurological and psychiatric abnormalities. A combination of copper chelators and zinc therapy has been used to prevent disease progression; however, accurate and timely diagnosis of the disease remains challenging. Similarly, side effects of treatments are common. To understand better the biochemical and cellular basis of Wilson's disease, several animal models have been developed. This review focuses on genetically engineered Atp7b-/- mice and describes the properties of these knockout animals, insights into the disease progression generated using Atp7b-/- mice, as well as advantages and limitations of Atp7b-/- mice as an experimental model for Wilson's disease.

AB - Wilson's disease is a severe human disorder of copper homoeostasis. The disease is associated with various mutations in the ATP7B gene that encodes a copper-transporting ATPase, and a massive accumulation of copper in the liver and several other tissues. The most frequent disease manifestations include a wide spectrum of liver pathologies as well as neurological and psychiatric abnormalities. A combination of copper chelators and zinc therapy has been used to prevent disease progression; however, accurate and timely diagnosis of the disease remains challenging. Similarly, side effects of treatments are common. To understand better the biochemical and cellular basis of Wilson's disease, several animal models have been developed. This review focuses on genetically engineered Atp7b-/- mice and describes the properties of these knockout animals, insights into the disease progression generated using Atp7b-/- mice, as well as advantages and limitations of Atp7b-/- mice as an experimental model for Wilson's disease.

KW - ATP7A

KW - ATP7B

KW - Copper

KW - Liver

KW - Mouse model

KW - Wilson's disease

UR - http://www.scopus.com/inward/record.url?scp=59149094700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59149094700&partnerID=8YFLogxK

U2 - 10.1042/BST0361233

DO - 10.1042/BST0361233

M3 - Article

C2 - 19021531

AN - SCOPUS:59149094700

VL - 36

SP - 1233

EP - 1238

JO - Biochemical Society Transactions

JF - Biochemical Society Transactions

SN - 0300-5127

IS - 6

ER -